期刊文献+

骨肉瘤MG-63细胞中Polo样激酶2的表达和定位 被引量:1

Expression and localization of Polo-like kinase 2 in osteosarcoma cells
下载PDF
导出
摘要 目的:构建真核表达载体*3 Flag-hPlk2并检测其在骨肉瘤细胞内的表达及定位。方法:以GST-hPlk2为模板,利用PCR扩增hPlk2基因cDNA全长,并将其克隆至含有*3 Flag标签的真核表达载体中。将构建的重组质粒进行酶切和测序鉴定,并转染到骨肉瘤细胞MG-63中,提取细胞蛋白进行Western blot检测。利用共聚焦激光扫描显微镜观察*3 Flag-hPlk2在MG-63细胞中的定位,免疫沉淀法纯化hPlk2蛋白。结果:hPlk2基因cDNA全长成功构建到真核表达载体*3 Flag中,Western blot检测到*3 Flag-hPlk2融合蛋白表达,分子量约为80kDa。*3 Flag-hPlk2在骨肉瘤MG-63细胞中主要定位于细胞质和核周,并成功纯化hPlk2蛋白。结论:成功构建了*3 Flag-hPlk2真核表达质粒,同时鉴定了*3 Flag-hPlk2融合蛋白的表达,并纯化hPlk2蛋白。*3 Flag-hPlk2蛋白主要定位在细胞质和核周。 Objective:To construct the expression plasmid of human Polo-like kinase 2(hPlk2) gene and identify the expression and localization of hPlk2 in osteosarcoma MG-63 cells.Methods: Human Plk2 coding sequence was obtained by polymerase chain reaction(PCR) amplification and cloned into 3* Flag vector.After the target region was identified by enzyme digestion and sequencing,the plasmid was transfected into osteosarcoma MG-63 cells.The expression of the recombinant plasmid in MG-63 cells was detected by Western blot.The localization of 3* Flag-hPlk2 in MG-63 cells was observed with laser scanning confocal microscopy.Purify the hPlk2 protein by immunoprecipitation assay.Results: hPlk2 was constructed into the expressing vector 3* Flag successfully.The length of the fragment identified by restriction enzyme digestion was 2058bp.The expression of 3* Flag-hPlk2 fusion protein with a molecular weight of 80kDa was detected by Western blot and pulled down by Flag antibody,and its localization was in the cytoplasm and perinucleus in MG-63 cells.Conclusion: The recombinant plasmid of hPlk2 gene was successfully cloned into eukaryotic expressing vector,and the expression of 3* Flag-hPlk2 fusion protein was identified and pulled down by Flag antibody,expressed in cytoplasm and perinucleus.
出处 《现代肿瘤医学》 CAS 2012年第5期882-885,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:30800415和81070688)
关键词 hPlk2 WESTERN BLOT 免疫沉淀 hPlk2 Western blot immunoprecipitation
  • 相关文献

参考文献12

  • 1Archambault V,Glover DM.Polo-like kinases:conservation anddivergence in their functions and regulation[J].Nat Rev Mol CellBiol,2009,10(4):265-275.
  • 2Andrysik Z,Bernstein WZ,Deng L,et al.The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nu-cleolus[J].Nucleic Acids Res,2010,38(9):2931-2943.
  • 3de Carcer G,Manning G,Malumbres M.From Plk1 to Plk5:Functional evolution of polo-like kinases[J].Cell Cycle,2011,10(14):2255-2262.
  • 4Degenhardt Y,Lampkin T.Targeting Polo-like kinase in cancertherapy[J].Clin Cancer Res,2010,16(2):384-389.
  • 5Winkles JA,Alberts GF.Differential regulation of polo-like ki-nase 1,2,3,and 4 gene expression in mammalian cells and tis-sues[J].Oncogene,2005,24(2):260-266.
  • 6Burns TF,Fei P,Scata KA,et al.Silencing of the novel p53 tar-get gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel(taxol)-exposed cells[J].Mol Cell Biol,2003,23(16):5556-5571.
  • 7Inglis KJ,Chereau D,Brigham EF,et al.Polo-like kinase 2(PLK2)phosphorylates alpha-synuclein at serine 129 in centralnervous system[J].J Biol Chem,2009,284(5):2598-2602.
  • 8Liby K,Wu H,Ouyang B,et al.Identification of the human hom-ologue of the early-growth response gene Snk,encoding a serum-inducible kinase[J].DNA Seq,2001,11(6):527-533.
  • 9Tan LB,Chen KT,Yuan YC,et al.Identification of urine PLK2as a marker of bladder tumors by proteomic analysis[J].World JUrol,2010,28(1):117-122.
  • 10Syed N,Smith P,Sullivan A,et al.Transcriptional silencing ofPolo-like kinase 2(SNK/PLK2)is a frequent event in B-cellmalignancies[J].Blood,2006,107(1):250-256.

同被引文献7

  • 1J Condeelis,JE Segall.Intravital imaging of cell movement in tumours [J].Nat Rev Cancer,2003,3(12):921-930.
  • 2H Hugo,ML Ackland,T Blick,et al.Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression [J].J Cell Physiol,2007,213(2):374-383..
  • 3M Deckers,M van Dinther,J Buijs,et al.The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells [J].Cancer Res,2006,66(4):2202-2209..
  • 4SB Pakala,K Singh,SD Reddy,et al.TGF-beta1 signaling targets metastasis-associated protein 1,a new effector in epithelial cells [J].Oncogene,2011,30(19):2230-2241..
  • 5C Dannenmann,N Shabani,K Friese,et al.The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer,represses ERbeta,and enhances expression of oncogenic cytokine GRO [J].Cancer Biol Ther,2008,7(9):1460-1467..
  • 6J Zavadil,EP Bottinger.TGF-beta and epithelial-to-mesenchymal transitions [J].Oncogene,2005,24 (37):5764-5774..
  • 7段维轶,徐中飞,朱伟,代炜,李瑞武,葛淑芬,孙长伏.舌癌、口底癌切除及即刻修复重建术中保存下颌牙槽突的可行性探讨[J].中国实用口腔科杂志,2011,4(9):552-553. 被引量:7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部